Non-Hodgkin lymphoma epidemiology and demographics: Difference between revisions

	Non-Hodgkin lymphoma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Non-Hodgkin's Lymphoma Differentiating Non-Hodgkin Lymphoma from Other Diseases Differentiating Types of Non-Hodgkin's Lymphoma
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
Staging
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Ultrasound
Biopsy
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Non-Hodgkin lymphoma epidemiology and demographics On the Web
Most recent articles
cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Non-Hodgkin lymphoma epidemiology and demographics All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Non-Hodgkin lymphoma epidemiology and demographics
CDC on Non-Hodgkin lymphoma epidemiology and demographics
Non-Hodgkin lymphoma epidemiology and demographics in the news
Blogs on Non-Hodgkin lymphoma epidemiology and demographics
Directions to Hospitals Treating Non-Hodgkin lymphoma
Risk calculators and risk factors for Non-Hodgkin lymphoma epidemiology and demographics

VisualWikitext

Revision as of 19:03, 12 June 2014

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Rim Halaby, M.D. [2]

Overview

Epidemiology and Demographics

Prevalence

In the United States, the age-adjusted prevalence of non-Hodgkin lymphoma is 131.1 per 100,000 in 2011.^[1]

Incidence

The delay-adjusted incidence of non-Hodgkin lymphoma in 2011 was estimated to be 20.2 per 100,000 persons in the United States.^[1]

In 2011, the age-adjusted incidence of non-Hodgkin lymphoma was 19.63 per 100,000 persons in the United States.^[1]

Age

While the overall age-adjusted incidence of non-Hodgkin lymphoma in the United States between 2007 and 2011 is 19.7 per 100,000, the age-adjusted incidence of non-Hodgkin lymphoma by age category is:^[1]
- Under 65 years: 9.3 per 100,000
- 65 and over: 91.5 per 100,000

Gender

In the United States, the age-adjusted prevalence of non-Hodgkin lymphoma by gender in 2011 is:^[1]
- In males: 150.4 %
- In females: 114.3 %

In the United States, the delay-adjusted incidence of non-Hodgkin lymphoma by gender in 2011 is:^[1]
- In males: 24.77 per 100,000 persons
- In females: 16.58 per 100,000 persons

In the United States, the age-adjusted incidence of non-Hodgkin lymphoma by gender on 2011 is:^[1]
- In males: 24.07 per 100,000 persons
- In females: 16.11 per 100,000 persons

Shown below is an image depicting the delay-adjusted incidence and observed incidence of non-Hodgkin lymphoma by gender and race in the United States between 1975 and 2011. These graphs are adapted from SEER: The Surveillance, Epidemiology, and End Results Program of the National Cancer Institute.^[1]

[Insert figure x.1 from the report]

Race

Shown below is a table depicting the age-adjusted prevalence of non-Hodgkin lymphoma by race in 2011 in the United States.^[1]

	All Races	White	Black	Asian/Pacific Islander	Hispanic
Age-adjusted prevalence	131.1 per 100,000	141.2 per 100,000	95.3 per 100,000	83.5 per 100,000	101.4 per 100,000

Shown below is an image depicting the incidence of non-Hodgkin lymphoma by race in the United States between 1975 and 2011.^[1]

[Insert figure x.2 from the report]

API: Asian/Pacific Islander; AI/AN: American Indian/ Alaska Native

References

↑ ^1.0 ^1.1 ^1.2 ^1.3 ^1.4 ^1.5 ^1.6 ^1.7 ^1.8 ^1.9 Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.

Template:Hematology

Template:WikiDoc Sources

[SEER-1] 1.0 ^1.1 ^1.2 ^1.3 ^1.4 ^1.5 ^1.6 ^1.7 ^1.8 ^1.9 Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.

[1]

@@ Line 1: / Line 1: @@
 __NOTOC__
 {{Non-Hodgkin lymphoma}}
+{{CMG}}; {{AE}} {{Rim}}
-Please help WikiDoc by adding more content here.  It's easy!  Click  [[Help:How_to_Edit_a_Page|here]]  to learn about editing.
+==Overview==
+==Epidemiology and Demographics==
+===Prevalence===
+* In the United States, the age-adjusted [[prevalence]] of non-Hodgkin lymphoma is 131.1 per 100,000 in 2011.<ref name="SEER">Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.</ref>
+===Incidence===
+* The delay-adjusted [[incidence]] of non-Hodgkin lymphoma in 2011 was estimated to be 20.2 per 100,000 persons in the United States.<ref name="SEER">Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.</ref>
+* In 2011, the age-adjusted [[incidence]] of non-Hodgkin lymphoma was 19.63 per 100,000 persons in the United States.<ref name="SEER">Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.</ref>
+===Age===
+* While the overall age-adjusted [[incidence]] of non-Hodgkin lymphoma in the United States between 2007 and 2011 is 19.7 per 100,000, the age-adjusted [[incidence]] of non-Hodgkin lymphoma by age category is:<ref name="SEER">Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.</ref>
+** Under 65 years: 9.3 per 100,000
+** 65 and over: 91.5 per 100,000
+===Gender===
+* In the United States, the age-adjusted [[prevalence]] of non-Hodgkin lymphoma by gender in 2011 is:<ref name="SEER">Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.</ref>
+** In males: 150.4 %
+** In females: 114.3 %
+* In the United States, the delay-adjusted [[incidence]] of non-Hodgkin lymphoma by gender in 2011 is:<ref name="SEER">Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.</ref>
+** In males: 24.77 per 100,000 persons
+** In females: 16.58 per 100,000 persons
+* In the United States, the age-adjusted [[incidence]] of non-Hodgkin lymphoma by gender on 2011 is:<ref name="SEER">Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.</ref>
+** In males: 24.07 per 100,000 persons
+** In females: 16.11 per 100,000 persons
+* Shown below is an image depicting the delay-adjusted [[incidence]] and observed [[incidence]] of non-Hodgkin lymphoma by gender and race in the United States between 1975 and 2011.  These graphs are adapted from [[SEER]]: The Surveillance, Epidemiology, and End Results Program of the National Cancer Institute.<ref name="SEER">Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.</ref>
+[Insert figure x.1 from the report]
+===Race===
+* Shown below is a table depicting the age-adjusted [[prevalence]] of non-Hodgkin lymphoma by race in 2011 in the United States.<ref name="SEER">Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.</ref>
+{| style="cellpadding=0; cellspacing= 0; width: 600px;"
+|-
+|style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center | || style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center |'''All Races''' ||style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center |'''White''' || style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center |'''Black''' || style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center |'''Asian/Pacific Islander'''  || style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center |'''Hispanic'''
+|-
+| style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center |'''Age-adjusted [[prevalence]]'''|| style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |131.1 per 100,000 ||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |141.2 per 100,000||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |95.3 per 100,000||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |83.5 per 100,000||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |101.4 per 100,000
+|}
+* Shown below is an image depicting the [[incidence]] of non-Hodgkin lymphoma by race in the United States between 1975 and 2011.<ref name="SEER">Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.</ref>
+[Insert figure x.2 from the report]
+<small> API: Asian/Pacific Islander; AI/AN: American Indian/ Alaska Native</small>
 ==References==
@@ Line 9: / Line 62: @@
 {{Hematology}}
 {{Hematological malignancy histology}}
-[[bn:অ-হজকিনের লসিকার্বুদ]]
-[[de:Non-Hodgkin-Lymphom]]
-[[es:Linfomas no-Hodgkins]]
-[[fr:Lymphome non-hodgkinien]]
-[[nl:Non-Hodgkin]]
-[[ja:非ホジキンリンパ腫]]
-[[pl:Chłoniaki nieziarnicze]]
-[[pt:Linfoma não-Hodgkin]]
-[[fi:Non-Hodgkinin lymfooma]]
-[[sv: Non-Hodgkins lymfom]]
 [[Category:Hematology]]

v t e Myeloid Hematological malignancy/leukemia histology (ICD-O 9590-9989, C81-C96, 200-208)
CFU-GM/ and other granulocytes	Template:Navbox subgroup
MEP	Template:Navbox subgroup
CFU-Mast	Mastocytoma (Mast cell leukemia, Mast cell sarcoma, Systemic mastocytosis)
Multiple/unknown	AML (Acute panmyelosis with myelofibrosis, Myeloid sarcoma) · MP (Myelofibrosis) · Acute biphenotypic leukaemia
See also hematology, lymphoid malignancy